Literature DB >> 29913556

Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis.

Thomas W Carion1, Matthew Greenwood2, Abdul Shukkur Ebrahim1, Andrew Jerome1, Susmit Suvas1,3,4, Karsten Gronert2, Elizabeth A Berger1,3.   

Abstract

Although autacoids primarily derived from the cyclooxygenase-2 and 5-lipoxygenase (LOX) pathways are essential mediators of inflammation, endogenous specialized proresolving mediators (SPMs) act as robust agonists of resolution. SPM biosynthesis is initiated by the conversion of arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid primarily via the 12/15-LOX pathway. Although 12/15-LOX activity is prominent in the cornea, the role of SPM pathway activation during infection remains largely unknown and is the focus of the current study. Pseudomonas keratitis was induced in resistant BALB/c and susceptible C57BL/6 (B6) mice. Biosynthetic pathways for proinflammatory autacoids and SPMs were assessed. Divergent lipid mediator profiles demonstrate the importance of 15-LOX pathways in the pathogenesis of ocular infectious disease. Results indicate that an imbalance of LOX enzymatic pathways contributes to susceptibility observed in B6 mice where deficient activation of SPM circuits, as indicated by reduced 15-hydroxy-eicosatetraenoic acid and 17-hydroxydocosahexaenoic acid levels, prevented transition toward resolution and led to chronic inflammation. In sharp contrast, BALB/c mice demonstrated a well-balanced axis of 5-LOX/12-LOX/15-LOX pathways, resulting in sufficient proresolving bioactive metabolite formation and immune homeostasis. Furthermore, a novel immunoregulatory role for 15-LOX was revealed in inflammatory cells (polymorphonuclear leukocytes and macrophages), which influenced phagocytic activity. These data provide evidence that SPM circuits are essential for host defense during bacterial keratitis.-Carion, T. W., Greenwood, M., Ebrahim, A. S., Jerome, A., Suvas, S., Gronert, K., Berger, E. A. Immunoregulatory role of 15-lipoxygenase in the pathogenesis of bacterial keratitis.

Entities:  

Keywords:  inflammation; lipid mediators; ocular infection; resolution

Mesh:

Substances:

Year:  2018        PMID: 29913556      PMCID: PMC6103176          DOI: 10.1096/fj.201701502R

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  51 in total

1.  Macrophages restrict Pseudomonas aeruginosa growth, regulate polymorphonuclear neutrophil influx, and balance pro- and anti-inflammatory cytokines in BALB/c mice.

Authors:  Sharon A McClellan; Xi Huang; Ronald P Barrett; Nico van Rooijen; Linda D Hazlett
Journal:  J Immunol       Date:  2003-05-15       Impact factor: 5.422

2.  Resolvin E1 improves tear production and decreases inflammation in a dry eye mouse model.

Authors:  Na Li; Jiucheng He; Carl Eric Schwartz; Per Gjorstrup; Haydee E P Bazan
Journal:  J Ocul Pharmacol Ther       Date:  2010-10       Impact factor: 2.671

3.  Efficacy of VIP as Treatment for Bacteria-Induced Keratitis Against Multiple Pseudomonas aeruginosa Strains.

Authors:  Thomas W Carion; Cody R McWhirter; Daiyajot K Grewal; Elizabeth A Berger
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-10       Impact factor: 4.799

4.  Prolonged elevation of IL-1 in Pseudomonas aeruginosa ocular infection regulates macrophage-inflammatory protein-2 production, polymorphonuclear neutrophil persistence, and corneal perforation.

Authors:  X L Rudner; K A Kernacki; R P Barrett; L D Hazlett
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

5.  Epithelial and corneal thickness measurements by in vivo confocal microscopy through focusing (CMTF).

Authors:  H F Li; W M Petroll; T Møller-Pedersen; J K Maurer; H D Cavanagh; J V Jester
Journal:  Curr Eye Res       Date:  1997-03       Impact factor: 2.424

6.  Substance P delays apoptosis, enhancing keratitis after Pseudomonas aeruginosa infection.

Authors:  Zimei Zhou; Ronald P Barrett; Sharon A McClellan; Yunfan Zhang; Elizabeth A Szliter; Nico van Rooijen; Linda D Hazlett
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-06-19       Impact factor: 4.799

7.  Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products.

Authors:  F Colotta; F Re; N Polentarutti; S Sozzani; A Mantovani
Journal:  Blood       Date:  1992-10-15       Impact factor: 22.113

Review 8.  Corneal response to Pseudomonas aeruginosa infection.

Authors:  Linda Dondero Hazlett
Journal:  Prog Retin Eye Res       Date:  2004-01       Impact factor: 21.198

9.  Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1.

Authors:  Gabrielle Fredman; Sungwhan F Oh; Srinivas Ayilavarapu; Hatice Hasturk; Charles N Serhan; Thomas E Van Dyke
Journal:  PLoS One       Date:  2011-09-14       Impact factor: 3.240

10.  Infection regulates pro-resolving mediators that lower antibiotic requirements.

Authors:  Nan Chiang; Gabrielle Fredman; Fredrik Bäckhed; Sungwhan F Oh; Thad Vickery; Birgitta A Schmidt; Charles N Serhan
Journal:  Nature       Date:  2012-04-25       Impact factor: 49.962

View more
  10 in total

1.  A Contrast in Pathogenic Responses between C57BL/6J and BALB/cJ Mice Using a Model of Retinal Injury.

Authors:  Haoshen Shi; Abdul S Ebrahim; Elizabeth A Berger
Journal:  Am J Pathol       Date:  2018-09-18       Impact factor: 4.307

Review 2.  VIP modulates the ALX/FPR2 receptor axis toward inflammation resolution in a mouse model of bacterial keratitis.

Authors:  Thomas W Carion; David Kracht; Eliisa Strand; Edwin David; Cody McWhirter; Abdul Shukkur Ebrahim; Elizabeth A Berger
Journal:  Prostaglandins Other Lipid Mediat       Date:  2018-12-04       Impact factor: 3.072

3.  A Dual Role for Cysteinyl Leukotriene Receptors in the Pathogenesis of Corneal Infection.

Authors:  Thomas W Carion; Yuxin Wang; Ashten Stambersky; Abdul Shukkur Ebrahim; Elizabeth A Berger
Journal:  J Immunol       Date:  2022-04-25       Impact factor: 5.426

4.  Structural and mechanistic insights into 5-lipoxygenase inhibition by natural products.

Authors:  Nathaniel C Gilbert; Jana Gerstmeier; Erin E Schexnaydre; Friedemann Börner; Ulrike Garscha; David B Neau; Oliver Werz; Marcia E Newcomer
Journal:  Nat Chem Biol       Date:  2020-05-11       Impact factor: 15.040

Review 5.  The potential of lipid mediator networks as ocular surface therapeutics and biomarkers.

Authors:  Becca A Flitter; Xiaohui Fang; Michael A Matthay; Karsten Gronert
Journal:  Ocul Surf       Date:  2020-04-29       Impact factor: 5.033

6.  Adjunctive Thymosin Beta-4 Treatment Influences MΦ Effector Cell Function to Improve Disease Outcome in Pseudomonas aeruginosa-Induced Keratitis.

Authors:  Yuxin Wang; Thomas W Carion; Abdul Shukkur Ebrahim; Gabriel Sosne; Elizabeth A Berger
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

7.  Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy Improves Pseudomonas aeruginosa-Induced Keratitis.

Authors:  Thomas W Carion; Abdul Shukkur Ebrahim; David Kracht; Aditya Agrawal; Eliisa Strand; Omar Kaddurah; Cody R McWhirter; Gabriel Sosne; Elizabeth A Berger
Journal:  Cells       Date:  2018-09-20       Impact factor: 6.600

8.  Antimicrobial Effects of Thymosin Beta-4 and Ciprofloxacin Adjunctive Therapy in Pseudomonas aeruginosa Induced Keratitis.

Authors:  Thomas W Carion; Abdul Shukkur Ebrahim; Spandana Alluri; Thanzeela Ebrahim; Tressa Parker; Julia Burns; Gabriel Sosne; Elizabeth A Berger
Journal:  Int J Mol Sci       Date:  2020-09-18       Impact factor: 5.923

9.  Adjunctive Thymosin Beta-4 Treatment Influences PMN Effector Cell Function during Pseudomonas aeruginosa-Induced Corneal Infection.

Authors:  Yuxin Wang; Thomas W Carion; Abdul Shukkur Ebrahim; Gabriel Sosne; Elizabeth A Berger
Journal:  Cells       Date:  2021-12-18       Impact factor: 6.600

Review 10.  Specialized proresolving mediators in infection and lung injury.

Authors:  Shayna Sandhaus; Andrew G Swick
Journal:  Biofactors       Date:  2020-11-28       Impact factor: 6.438

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.